The cough remedies market has seen considerable growth due to a variety of factors.
• The cough remedies market has grown significantly in recent years. It will rise from $11.06 billion in 2024 to $12.04 billion in 2025, at a compound annual growth rate (CAGR) of 8.9%.
This growth is attributed to increased government healthcare expenditure, greater awareness of natural cough remedies, and higher vehicle emissions.
The cough remedies market is expected to maintain its strong growth trajectory in upcoming years.
• The cough remedies market is expected to grow to $16.76 billion by 2029, at a CAGR of 8.6%.
Growth drivers include the increasing prevalence of respiratory diseases, the aging population, innovations in cough treatments, high demand for OTC products, air pollution, and rising self-care awareness. Trends include investments in new formulations, company partnerships, and innovations in lozenges and candy.
The growth of respiratory diseases is anticipated to drive the expansion of the cough remedies market. Respiratory diseases cover a wide range of conditions affecting the organs and tissues responsible for breathing and gas exchange in humans and other air-breathing animals. The rise in respiratory illnesses is attributed to factors like higher exposure to environmental pollutants, dense living conditions, and greater vehicle emissions. Cough remedies such as expectorants aid in thinning mucus in the airways, making it easier for patients to clear their lungs through coughing. This offers relief and supports recovery, particularly for patients with sore throats or irritated airways. For example, in July 2024, the American Lung Association reported that asthma prevalence in the US increased from 12.9% of the population in 2021 to 13.5% in 2022. This growing incidence of respiratory diseases drives the cough remedies market.
The cough remedies market covered in this report is segmented –
1) By Product Type: Expectorants, Antihistamine, Bronchodilator, Decongestants, Antibiotics
2) By Dosage Form: Oral Syrup, Tablets Or Pills, Nasal Drop, Lozenges
3) By Age Group : Pediatric, Adult
4) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Pharmacy
Subsegments:
1) By Expectorants: Guaifenesin-Based Products, Acetylcysteine-Based Products, Combination Expectorants
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines, Combination Products
3) By Bronchodilators: Beta-Agonists, Anticholinergics, Combination Bronchodilators
4) By Decongestants: Oral Decongestants, Nasal Sprays, Combination Products
5) By Antibiotics: Macrolides, Penicillins, Cephalosporins, Fluoroquinolones, Combination Antibiotics
Major companies in the cough remedies market are introducing herbal cough syrups to enhance treatment options. In January 2023, Megalabs, a pharmaceutical company from Uruguay, launched Prospan herbal cough syrup, made from EA575, an extract from ivy leaves. This non-drowsy, sugar-free syrup reduces cough, chest congestion, and airway inflammation.
Major companies operating in the cough remedies market are:
• Pfizer Inc.
• The Procter & Gamble Company (P&G)
• Johnson & Johnson Inc.
• Merck & Co. Inc.
• Bayer AG
• Sanofi S.A.
• AstraZeneca Plc
• Novartis AG
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Reckitt Benckiser Group
• Perrigo Lab India Private Limited
• Prestige Brands Holdings Inc.
• Hyland's Inc.
• Boiron
• Chattem Chemicals Inc.
• Tris Pharma Inc.
• Mayne Pharma Inc.
• Zarbee's Inc.
• Genexa Inc.
North America was the largest region in the cough remedies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cough remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.